Literature DB >> 23428929

Cytokines and NO in American tegumentary leishmaniasis patients: profiles in active disease, after therapy and in self-healed individuals.

Marina de Assis Souza1, Maria C A Brelaz de Castro, Andresa Pereira de Oliveira, Amanda Ferreira de Almeida, Thays Miranda de Almeida, Luiza C Reis, Ângela Cristina Rapela Medeiros, Maria Edileuza Felinto de Brito, Valéria Rêgo Alves Pereira.   

Abstract

Studies suggest the influence of immune response on the successful treatment of American tegumentary leishmaniasis (ATL), and indicate the existence of protective immunity in self-healed patients. Thus, the aim of this work was to quantify interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), interleukin (IL-) 10, IL-17, IL-22 and nitric oxide (NO) in culture supernatants of PBMC from patients with active disease (AD), after treatment (AT), and from self-healed (SH) and healthy subjects (CT), in response to Leishmania (Viannia) braziliensis insoluble antigen (AgIns). All groups of patients produced IFN-γ, indicating a predominant proinflammatory profile. AD and AT patients presented TNF-α levels, with a slight increase after therapy, whereas it was weakly quantified in SH. Interestingly, NO secretion was significant in these individuals, whereas IL-17 appeared in low levels and seems to be regulated by NO. Although IL-22 was detected in AD, its role is still questionable. The presence of IL-10 in all groups of patients suggests that the cytokine plays distinct roles in the disease. These results indicate that specific cellular immunity takes part against Leishmania, but with some similarities between the different clinical states herein described; these mediators seem to be necessary for the cure to occur.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428929     DOI: 10.1016/j.micpath.2013.02.004

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  14 in total

1.  Age modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.

Authors:  Augusto M Carvalho; Camila F Amorim; Juliana L S Barbosa; Alexsandro S Lago; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

2.  Ex vivo host and parasite response to antileishmanial drugs and immunomodulators.

Authors:  Laura Gonzalez-Fajardo; Olga Lucía Fernández; Diane McMahon-Pratt; Nancy Gore Saravia
Journal:  PLoS Negl Trop Dis       Date:  2015-05-29

3.  CD4 T cell activation by B cells in human Leishmania (Viannia) infection.

Authors:  Daniel Rodriguez-Pinto; Nancy Gore Saravia; Diane McMahon-Pratt
Journal:  BMC Infect Dis       Date:  2014-02-25       Impact factor: 3.090

4.  Extracellular vesicles from Leishmania-infected macrophages confer an anti-infection cytokine-production profile to naïve macrophages.

Authors:  André Cronemberger-Andrade; Luciana Aragão-França; Cintia Figueiredo de Araujo; Viviane Junqueira Rocha; Mariana da Cruz Borges-Silva; Cláudio P Figueira; Cláudio P Figueiras; Pablo R Oliveira; Luiz A R de Freitas; Patrícia S T Veras; Lain Pontes-de-Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

5.  Leishmania infantum and Leishmania braziliensis: Differences and Similarities to Evade the Innate Immune System.

Authors:  Sarah de Athayde Couto Falcão; Tatiana M G Jaramillo; Luciana G Ferreira; Daniela M Bernardes; Jaime M Santana; Cecília B F Favali
Journal:  Front Immunol       Date:  2016-08-03       Impact factor: 7.561

6.  The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy.

Authors:  Ines Lakhal-Naouar; Bonnie M Slike; Naomi E Aronson; Mary A Marovich
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

7.  Combination of In Silico Methods in the Search for Potential CD4(+) and CD8(+) T Cell Epitopes in the Proteome of Leishmania braziliensis.

Authors:  Rafael de Freitas E Silva; Luiz Felipe Gomes Rebello Ferreira; Marcelo Zaldini Hernandes; Maria Edileuza Felinto de Brito; Beatriz Coutinho de Oliveira; Ailton Alvaro da Silva; Osvaldo Pompílio de-Melo-Neto; Antônio Mauro Rezende; Valéria Rêgo Alves Pereira
Journal:  Front Immunol       Date:  2016-08-29       Impact factor: 7.561

Review 8.  The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis.

Authors:  Suênia da C Gonçalves-de-Albuquerque; Rômulo Pessoa-E-Silva; Lays A M Trajano-Silva; Tayná Correia de Goes; Rayana C S de Morais; Cíntia N da C Oliveira; Virgínia M B de Lorena; Milena de Paiva-Cavalcanti
Journal:  Front Immunol       Date:  2017-10-30       Impact factor: 7.561

9.  PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis.

Authors:  Daniel Holanda Barroso; Sarah De Athayde Couto Falcão; Jorgeth de Oliveira Carneiro da Motta; Laís Sevilha Dos Santos; Gustavo Henrique Soares Takano; Ciro Martins Gomes; Cecília Beatriz Fiuza Favali; Beatriz Dolabela de Lima; Raimunda Nonata Ribeiro Sampaio
Journal:  Front Immunol       Date:  2018-05-11       Impact factor: 7.561

10.  miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection.

Authors:  Marina de Assis Souza; Eduardo Milton Ramos-Sanchez; Sandra Márcia Muxel; Dimitris Lagos; Luiza Campos Reis; Valéria Rêgo Alves Pereira; Maria Edileuza Felinto Brito; Ricardo Andrade Zampieri; Paul Martin Kaye; Lucile Maria Floeter-Winter; Hiro Goto
Journal:  Front Cell Infect Microbiol       Date:  2021-06-10       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.